We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Bayer HealthCare Licenses Genomatix’ Microarray Analysis Platform ChipInspector
News

Bayer HealthCare Licenses Genomatix’ Microarray Analysis Platform ChipInspector

Bayer HealthCare Licenses Genomatix’ Microarray Analysis Platform ChipInspector
News

Bayer HealthCare Licenses Genomatix’ Microarray Analysis Platform ChipInspector

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Bayer HealthCare Licenses Genomatix’ Microarray Analysis Platform ChipInspector"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Genomatix has announced that Bayer HealthCare licensed Genomatix microarray analysis platform ChipInspector.

ChipInspector is designed to enable biologists and bio-informaticians to analyze chip raw data from Affymetrix GeneChip and Exon Arrays.

It employs a proprietary single probe approach based on latest genomic annotation from Genomatix' ElDorado annotation pipeline.

Starting with ChipInspector the Genomatix Microarray Analysis Pipeline integrates literature and pathway mining as well as promoter analysis on sequence level in one coherent system.

"After several successful pilot studies we are now very pleased that Bayer HealthCare licensed ChipInspector," states Dr. Martin Seifert, VP Microarray business and collaborative research.

"We expect that ChipInspector will enhance the Affymetrix analysis pipeline starting from GeneChip and Exon Arrays at Bayer." 

Advertisement